Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

merckincweb1

MSD under CMA investigation over unfair Remicade pricing

May 24, 2017 Research and Development, Sales and Marketing Competition and Marketing Authority, MSD, Remicade

MSD is facing legal trouble after the Competition and Marketing Authority (CMA) alleged that the pharmaceutical firm had engaged in …
News
scott_gottlieb

Opioid crisis “highest initial priority” for new FDA Commissioner

May 24, 2017 Medical Communications, Research and Development FDA, Scott Gottlieb, opioid, opioid crisis

Scott Gottlieb, the newly appointment FDA Commissioner, has indicated that his first priority is to tackle the opioid crisis currently …
News
pharmafocus_june_2017_cover

The June 2017 issue of Pharmafocus is now live!

May 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders

The latest edition of Pharmafocus is available to read online now!
News

European approval for novel Eisai epilepsy monotherapy

May 23, 2017 Research and Development, Sales and Marketing Bial, Eisai, Zebinix, epilepsy

Eisai and Bial have revealed that their drug Zebinix (eslicarbazepine acetate) has been awarded marketing authorisation by the European Commission …
News
2919193_kenneth

Nativis Incorporated appoints new CSO

May 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis

Nativis, a clinical stage life science bio-clectronic company, has appointed Dr Kenneth Ferguson to the position of Chief Scientific Officer. …
Appointment
astrazeneca_plaque

Strong showing for AZ asthma drug, but diabetes treatment flops

May 23, 2017 Manufacturing and Production, Research and Development AstraZeneca, asthma, diabetes

AstraZeneca has been mulling over mixed news this week after both its severe asthma treatment and diabetes therapy saw varying …
News
janeg

J&J lines up its Global Head for Actelion

May 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Janssen, Johnson & Johnson

The deal is not yet complete but the last steps are assumed to be a formality – at least Johnson …
Appointment

Behind the NHS recruitment crisis

May 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS Providers

NHS Providers, the membership organisation and trade association for the NHS, laid a stark warning at the door of the …
Feature

Novartis cuts 500 traditional roles for 350 ‘high-tech’ ones

May 22, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Novartis

Novartis has announced a restructure within the company which will lead to the transfer or loss of 500 traditional production …
News
amgen_hq

Amgen hit by major safety blow on osteoporosis drug

May 22, 2017 Research and Development, Sales and Marketing Amgen, Romosozumab, UCB SA

Amgen and UCB SA have been delivered a crushing blow in its attempt to have a drug for osteoporosis approved …
News
melanoma

No causal link between Viagra use and melanoma, study finds

May 19, 2017 Medical Communications, Research and Development melanoma, viagra

Research from the NYU Langone Medical Center and its Perlmutter Cancer Center, based in New York City, has indicated that …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

With every week we draw closer to the event everyone in the UK is talking about – the general election. …
News
lungs

Off-patent cancer drug holds promise for severe asthma treatment

May 18, 2017 Research and Development asthma, imatinib

Researchers from Brigham and Women’s Hospital and Harvard Medical School have conducted a small-scale study into the prospect of using …
News

FDA approves first ALS/Lou Gehrig’s disease therapy in 22 years

May 18, 2017 Research and Development, Sales and Marketing Mitsubishi Tanabe Pharma, als

The FDA has announced that it has approved Mitsubishi Tanabe Pharma’s Radicava (edaravone) for the treatment of amyotrophic lateral sclerosis(ALS), …
News
pills-384846_960_720

Research suggests opioid crisis stems from prescription approach

May 18, 2017 Medical Communications, Research and Development opioid crisis, opioids

The opioid crisis that is currently gripping North America is gaining more and more news traction as the damage to …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026